News | January 16, 2009

SNM Cautions that Domestic Isotope Shortages Remain

January 16, 2009 - According to a report released Jan. 14, 2009, by the National Academy of Sciences (NAS), eliminating the highly enriched uranium process (HEU) — the primary source of medical isotopes in the U.S. — would be technically and economically feasible; however, the conversion to an alternative source will be years away, is likely to be more costly than the report estimates and will not alleviate the current ongoing shortages of medically necessary isotopes, according to the Society of Nuclear Medicine.

The NAS report, "Medical Isotope Production Without Highly Enriched Uranium," was mandated by Congress to examine the feasibility of conversion from HEU to a low enriched uranium (LEU) process and to make recommendations for how such a change may be made.

"The NAS report does not address concerns about isotope production that could have significant impact for patients requiring common diagnostic procedures," said Robert W. Atcher, Ph.D., M.B.A., president of SNM and chair of SNM's Isotope Availability Taskforce. "We are pleased by the prudent recommendations of the report and long-term view toward the potential conversion from HEU. However, the information used for developing the economic impact is suspect and the need for a reliable domestic isotope supply remains critical and is not addressed by this report, and continues to put patients at risk."

The majority of the U.S.' supply of medical radioisotopes is produced using HEU targets at reactors in Canada and Europe. In addition, there are currently no domestic producers of Molybdenum-99 (Mo-99)— from which Technectium-99m (Tc-99m) is derived—which is produced from HEU. The U.S. continues to rely on five facilities outside the country, which in the recent past have been unreliable due to their age and need for regular maintenance in addition to unscheduled outages due to safety and maintenance issues. Any disruption at these facilities causes significant delays to patients receiving nuclear medicine and molecular imaging procedures.

While the NAS report focuses on potential security concerns related to isotope production using HEU, there are significant regulatory, financial, environmental and patient issues linked with a conversion to LEU that must be taken into consideration before making any large-scale changes, said SNM.

"The report makes some prudent recommendations for a move away from HEU, such as involving the U.S. Food and Drug Administration early on in the conversion process," said Atcher. "Our concern is for our patients who benefit from molecular imaging and nuclear medicine tests for the detection and staging of cancer and other conditions. In addition, there is concern that the economic issues associated with the conversion to LEU production have not been adequately assessed nor addressed."

Continuing shutdowns due to maintenance work at the world's nuclear reactors that manufacture Mo-99 have increased the urgency of finding an alternative reliable domestic source for Mo-99.

For more information:

Related Content

NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...